Recombinant IL4 (Pascolizumab Biosimilar) antibody

Catalog No. ABIN7597899

This Humanized Chimeric antibody specifically detects IL4 (Pascolizumab Biosimilar) in not_set. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL4 (Pascolizumab Biosimilar) antibody (ABIN7597899)

Target: IL4 (Pascolizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This IL4 (Pascolizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL4 (Pascolizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Pascolizumab Biosimilar Antibody

Specificity: Binetrakin, B-cell stimulatory factor 1, Pitrakinra, Lymphocyte stimulatory factor 1, IL-4, BSF-1, IL4, Interleukin-4

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 2.15 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL4 (Pascolizumab Biosimilar)

Target: IL4 (Pascolizumab Biosimilar)

Alternative Name: Pascolizumab Biosimilar

Target Type: Biosimilar

Background: Binetrakin, B-cell stimulatory factor 1, Pitrakinra, Lymphocyte stimulatory factor 1, IL-4, BSF-1, IL4, Interleukin-4

UniProt: P05112

CAS-No: 331243-22-2